These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38512467)

  • 21. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of schizophrenia diagnosis in a 10-year longitudinal study on first episode of non-affective psychosis: Conclusions from the PAFIP cohort.
    Suárez-Pinilla P; Suárez-Pinilla M; Setién-Suero E; Ortiz-García de la Foz V; Mayoral-Van Son J; Vázquez-Bourgon J; Gómez-Revuelta M; Juncal-Ruíz M; Ayesa-Arriola R; Crespo-Facorro B
    Acta Psychiatr Scand; 2021 Oct; 144(4):342-357. PubMed ID: 34228812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
    Cuesta MJ; Sánchez-Torres AM; Cabrera B; Bioque M; Merchán-Naranjo J; Corripio I; González-Pinto A; Lobo A; Bombín I; de la Serna E; Sanjuan J; Parellada M; Saiz-Ruiz J; Bernardo M;
    Schizophr Res; 2015 May; 164(1-3):65-73. PubMed ID: 25819935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.
    Treen Calvo D; Giménez-Donoso S; Setién-Suero E; Toll Privat A; Crespo-Facorro B; Ayesa Arriola R
    Schizophr Res; 2018 May; 195():320-326. PubMed ID: 28844434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobacco smoking and its association with cognition in first episode psychosis patients.
    Hickling LM; Perez-Iglesias R; Ortiz-García de la Foz V; Balanzá-Martínez V; McGuire P; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Feb; 192():269-273. PubMed ID: 28412088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in first-episode psychosis and in people at ultra-high risk.
    Cocchi A; Lora A; Meneghelli A; La Greca E; Pisano A; Cascio MT; Preti A; ;
    Psychiatry Res; 2014 Feb; 215(2):314-22. PubMed ID: 24355686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort.
    Vázquez-Bourgon J; Gómez-Revuelta M; Mayoral-van Son J; Labad J; Ortiz-García de la Foz V; Setién-Suero E; Ayesa-Arriola R; Tordesillas-Gutiérrez D; Juncal-Ruiz M; Crespo-Facorro B
    Eur Psychiatry; 2022 Aug; 65(1):e48. PubMed ID: 35971658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study.
    Pardo-de-Santayana G; Vázquez-Bourgon J; Gómez-Revuelta M; Ayesa-Arriola R; Ortiz-Garcia de la Foz V; Crespo-Facorro B; Pelayo-Terán JM;
    Schizophr Res; 2020 Jun; 220():240-247. PubMed ID: 32276867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
    Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Xie B; Li C; Wang J
    Aust N Z J Psychiatry; 2021 Mar; 55(3):314-323. PubMed ID: 33143440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premorbid adjustment as predictor of long-term functionality: Findings from a 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Ayesa-Arriola R; Peña J; Ojeda N; Crespo-Facorro B
    Psychiatry Res; 2024 Jan; 331():115674. PubMed ID: 38134530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study.
    Crespo-Facorro B; de la Foz VO; Ayesa-Arriola R; Pérez-Iglesias R; Mata I; Suarez-Pinilla P; Tabares-Seisdedos R; Vázquez-Barquero JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():162-7. PubMed ID: 23435091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.
    Rund BR; Melle I; Friis S; Larsen TK; Midbøe LJ; Opjordsmoen S; Simonsen E; Vaglum P; McGlashan T
    Am J Psychiatry; 2004 Mar; 161(3):466-72. PubMed ID: 14992972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance.
    Hidalgo-Figueroa M; Salazar A; Romero-López-Alberca C; MacDowell KS; García-Bueno B; Bioque M; Bernardo M; Parellada M; González-Pinto A; García Portilla MP; Lobo A; Rodriguez-Jimenez R; Berrocoso E; Leza JC; ;
    Int J Neuropsychopharmacol; 2022 Aug; 25(8):666-677. PubMed ID: 35353882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported quality of life in a Scottish first-episode psychosis cohort: associations with symptomatology and premorbid adjustment.
    MacBeth A; Gumley A; Schwannauer M; Fisher R
    Early Interv Psychiatry; 2015 Feb; 9(1):53-60. PubMed ID: 24034336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive functioning and cannabis use in first-episode psychosis.
    Karpov B; Lindgren M; Kieseppä T; Wegelius A; Suvisaari J
    Nord J Psychiatry; 2022 Oct; 76(7):551-558. PubMed ID: 34964681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive Inflexibility Predicts Negative Symptoms Severity in Patients with First-Episode Psychosis: A 1-Year Follow-Up Study.
    Mantonakis L; Stefanatou P; Tsionis A; Konstantakopoulos G; Xenaki LA; Ntigrintaki AA; Ralli I; Dimitrakopoulos S; Kollias K; Stefanis NC
    Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathways to violent behavior during first-episode psychosis: a report from the UK National EDEN Study.
    Winsper C; Singh SP; Marwaha S; Amos T; Lester H; Everard L; Jones P; Fowler D; Marshall M; Lewis S; Sharma V; Freemantle N; Birchwood M
    JAMA Psychiatry; 2013 Dec; 70(12):1287-93. PubMed ID: 24089149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse.
    Rund BR; Melle I; Friis S; Johannessen JO; Larsen TK; Midbøe LJ; Opjordsmoen S; Simonsen E; Vaglum P; McGlashan T
    Schizophr Res; 2007 Mar; 91(1-3):132-40. PubMed ID: 17258891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis users have higher premorbid IQ than other patients with first onset psychosis.
    Ferraro L; Russo M; O'Connor J; Wiffen BD; Falcone MA; Sideli L; Gardner-Sood P; Stilo S; Trotta A; Dazzan P; Mondelli V; Taylor H; Friedman B; Sallis H; La Cascia C; La Barbera D; David AS; Reichenberg A; Murray RM; Di Forti M
    Schizophr Res; 2013 Oct; 150(1):129-35. PubMed ID: 23958486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.